Alvotech (ALVO) financial statements

Healthcare · Drug Manufacturers - Specialty & Generic · Market cap $1.6B

Alvotech reported revenue of $586M in fiscal 2025, up 54.5% a year over 5 years.

Net income was $28M and the operating margin 13.3%, against -206.5% in 2020.

Free cash flow was -$146M.

The diluted share count rose 211% over the period (dilution).

Revenue and free cash flow

Fiscal years, $ billions.

-0.5-0.200.20.50.8202020212022202320242025RevenueFree cash flow
Embed this chart

Free to use in articles and newsletters with the source line. Paste this HTML:

Income statement

Fiscal years, from Alvotech's 10-K filings with the SEC.

Fiscal year202020212022202320242025
Revenue$67M$37M$83M$91M$490M$586M
Cost of revenue—$0$64M$161M$185M$236M
Gross profit—$37M$19M-$69M$304M$351M
Research and development$148M$191M$181M$211M$171M$184M
Selling, general and admin$59M$84M$187M$77M$66M$91M
Operating income-$138M-$235M-$346M-$355M$70M$78M
Interest expense$162M$117M$188M$267M$303M$149M
Pre-tax income-$292M-$149M-$552M-$651M-$218M$136M
Income tax-$122M-$48M-$38M-$99M$14M$108M
Net income-$170M-$102M-$514M-$552M-$232M$28M
EPS (diluted)-$1.82-$0.92-$2.60-$2.43-$0.87$0.10
Diluted shares94M111M198M227M268M291M
Gross margin—100.0%22.8%-75.9%62.2%59.8%
Operating margin-206.5%-640.3%-417.3%-388.1%14.2%13.3%
Net margin-255.3%-276.0%-618.6%-603.4%-47.3%4.8%

Balance sheet

Fiscal years, from Alvotech's 10-K filings with the SEC.

Fiscal year202020212022202320242025
Cash and short-term investments$32M$18M$66M$11M$51M$172M
Receivables—$29M$33M$41M$160M$70M
Inventory—$39M$71M$74M$128M$220M
Total current assets—$120M$231M$195M$455M$574M
Property, plant and equipment—$79M$221M$237M$285M$356M
Goodwill$13M$12M$12M$12M$11M$13M
Total assets—$598M$828M$950M$1.2B$1.5B
Total current liabilities—$112M$167M$261M$193M$304M
Long-term debt—$398M$745M$922M$1.0B$1.3B
Total liabilities—$734M$1.4B$1.9B$1.6B$1.8B
Shareholders' equity-$867M-$136M-$564M-$932M-$413M-$284M
Net debt-$32M$381M$698M$911M$984M$1.1B

Cash flow

Fiscal years, from Alvotech's 10-K filings with the SEC.

Fiscal year202020212022202320242025
Operating cash flow-$74M-$228M-$312M-$312M-$237M-$50M
Capital spending$12M$41M$49M$46M$57M$96M
Free cash flow-$86M-$269M-$361M-$359M-$294M-$146M
Stock-based compensation—$0$10M$18M$8M$7M
Dividends paid$0$0$0$0$0$0
Net borrowing$27M$76M$159M$179M$147M$208M
Free cash flow margin-129.5%-731.0%-435.3%-392.3%-60.0%-25.0%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ALVO.
Open ALVO in Investingly

Questions

What was Alvotech's revenue in 2025?

$586M in fiscal 2025, from its 10-K filing.

How much free cash flow does Alvotech generate?

-$146M in fiscal 2025 (operating cash flow minus capital spending).

From Alvotech's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.